Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
Manipulation of pre-mRNA processing is a promising approach toward overcoming disease-causing mutations and treating human diseases. We show that a combined treatment applying two splice-manipulating technologies improves therapeutic efficacies to correct mutation-induced splice defects. Previously,...
Main Authors: | Saskia Breuel, Mariann Vorm, Anja U. Bräuer, Marta Owczarek-Lipska, John Neidhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253119302276 |
Similar Items
-
Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
by: Tobias Bonifert, et al.
Published: (2016-01-01) -
On co-transcriptional splicing and U6 snRNA biogenesis
by: Listerman, Imke
Published: (2006) -
Corrigendum to “Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1”
Published: (2016-01-01) -
U5 snRNA Interactions With Exons Ensure Splicing Precision
by: Olga V. Artemyeva-Isman, et al.
Published: (2021-07-01) -
Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy
by: Dario Balestra, et al.
Published: (2019-08-01)